ConductScience.org, home

Paper11554010

The pathology of Parkinson's disease.

Jellinger KA. Adv Neurol, 2001. Cited by 151 papers, by iCite.

Cite this record

ConductScience Library. The pathology of Parkinson's disease. Papers, record 11554010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11554010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pathology of Parkinson's disease.
PubMed
Journal
Adv Neurol
PubMed
Year
2001
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
151
iCite
Relative citation ratio, by iCite
3.93
iCite
Revised in PubMed
2006-11-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jellinger KAK A

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BrainMajor topic
Neural PathwaysMajor topic
Parkinson DiseaseMajor topic
Humans

Cited by54

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 151 citations.

PMIDTitleJournalYearIn PapersSource
380018832,4-Dichlorophenoxyacetic Acid Induces Degeneration of mDA Neurons In Vitro.Biomedicines2023https://conductscience.org/library/papers/38001883PubMed
37213711Parkinson's genetics research on underrepresented AfrAbia populations: current state and future prospects.Am J Neurodegener Dis2023https://conductscience.org/library/papers/37213711PubMed
37185323Neuronal Vulnerability to Degeneration in Parkinson's Disease and Therapeutic Approaches.CNS Neurol Disord Drug Targets2024https://conductscience.org/library/papers/37185323PubMed
37063521The assessment of executive functions to test the integrity of the nigrostriatal network: A pilot study.Front Psychol2023https://conductscience.org/library/papers/37063521PubMed
35956957The Relationship between Procyanidin Structure and Their Protective Effect in a Parkinson's Disease Model.Molecules2022https://conductscience.org/library/papers/35956957PubMed
35900428A novel aged mouse model of recurrent intracerebral hemorrhage in the bilateral striatum.Neural Regen Res2023https://conductscience.org/library/papers/35900428PubMed
34148545Identification of sixteen novel candidate genes for late onset Parkinson's disease.Mol Neurodegener2021https://conductscience.org/library/papers/34148545PubMed
33669787Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review.Molecules2021https://conductscience.org/library/papers/33669787PubMed
33654110Human moral decision-making through the lens of Parkinson's disease.NPJ Parkinsons Dis2021https://conductscience.org/library/papers/33654110PubMed
31773419Neuroimaging in Vascular Parkinsonism.Curr Neurol Neurosci Rep2019https://conductscience.org/library/papers/31773419PubMed
29310988An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group.Parkinsonism Relat Disord2018https://conductscience.org/library/papers/29310988PubMed
29188488Lipopolysaccharide-Induced Microglia Activation Promotes the Survival of Midbrain Dopaminergic Neurons In Vitro.Neurotox Res2018https://conductscience.org/library/papers/29188488PubMed
29067118Tectorigenin attenuates the MPP+-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition.Exp Ther Med2017https://conductscience.org/library/papers/29067118PubMed
28883785Early Postnatal but Not Late Adult Neurogenesis Is Impaired in the Pitx3-Mutant Animal Model of Parkinson's Disease.Front Neurosci2017https://conductscience.org/library/papers/28883785PubMed
28659790Aging Microglia-Phenotypes, Functions and Implications for Age-Related Neurodegenerative Diseases.Front Aging Neurosci2017https://conductscience.org/library/papers/28659790PubMed
28429275TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson's Disease.J Neuroimmune Pharmacol2017https://conductscience.org/library/papers/28429275PubMed
28343366Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex.Mov Disord2017https://conductscience.org/library/papers/28343366PubMed
28337124Interleukin-4 Protects Dopaminergic Neurons In vitro but Is Dispensable for MPTP-Induced Neurodegeneration In vivo.Front Mol Neurosci2017https://conductscience.org/library/papers/28337124PubMed
27058446Biallelic Mutations in PDE10A Lead to Loss of Striatal PDE10A and a Hyperkinetic Movement Disorder with Onset in Infancy.Am J Hum Genet2016https://conductscience.org/library/papers/27058446PubMed
26869879Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson's Disease.Front Mol Neurosci2016https://conductscience.org/library/papers/26869879PubMed

See all 54 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11554010

GET https://conductscience.org/api/papers/v1/11554010/cited_by?page=2